News and Press Releases
Research CF Foundation Responds to FDA Decision on Aztreonam Lysine for Inhalation

On September 16, 2008, the U.S. Food and Drug Administration (FDA) issued a ruling on a drug being developed by Gilead Sciences, Inc. for the treatment of cystic fibrosis. 

Sept. 25, 2008 | 2 min read
About the CF Foundation | Advocacy Summer Advocacy Campaign Connects CF Community with Congress

In August, CF Advocates visited their representatives in the U.S. House as part of the CF Foundation's first ever national summer advocacy campaign, “House Calls.”

Sept. 2, 2008 | 1 min read